Canlyniadau Chwilio - Gere Sunder‐Plassmann

Mireinio'r Canlyniadau
  1. 1
    An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy

    An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy gan Christof Aigner, Alice Schmidt, Martina Gaggl, Gere Sunder‐Plassmann

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Recent insights into the molecular genetics of the homocysteine metabolism

    Recent insights into the molecular genetics of the homocysteine metabolism gan Manuela Födingeer, Oswald Wagner, Walter H. Hörl, Gere Sunder‐Plassmann

    Cyhoeddwyd 2001
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency.

    Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. gan Sanda Patruta, Roland Edlinger, Gere Sunder‐Plassmann, W.H. Hörl

    Cyhoeddwyd 1998
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Randomized, Single Blind, Controlled Trial to Evaluate the Prime-Boost Strategy for Pneumococcal Vaccination in Renal Transplant Recipients

    Randomized, Single Blind, Controlled Trial to Evaluate the Prime-Boost Strategy for Pneumococcal Vaccination in Renal Transplant Recipients gan Selma Tobudic, Veronika Plunger, Gere Sunder‐Plassmann, Markus Riegersperger, Heinz Burgmann

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Agalsidase Alfa Slows the Decline in Renal Function in Patients with Fabry Disease

    Agalsidase Alfa Slows the Decline in Renal Function in Patients with Fabry Disease gan Sandro Feriozzi, Andreas Schwarting, Gere Sunder‐Plassmann, Michael L. West, Markus Cybulla

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    A prospective study of anaemia and long-term outcomes in kidney transplant recipients

    A prospective study of anaemia and long-term outcomes in kidney transplant recipients gan Wolfgang C. Winkelmayer­, Anil Chandraker, M. Alan Brookhart, Reinhard Kramar, Gere Sunder‐Plassmann

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Anemia and Iron Deficiencies among Long-Term Renal Transplant Recipients

    Anemia and Iron Deficiencies among Long-Term Renal Transplant Recipients gan Matthias Lorenz, Josef Kletzmayr, Agnes Perschl, Alexander Furrer, Walter H. Hörl, Gere Sunder‐Plassmann

    Cyhoeddwyd 2002
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    The Effectiveness of Long-Term Agalsidase Alfa Therapy in the Treatment of Fabry Nephropathy

    The Effectiveness of Long-Term Agalsidase Alfa Therapy in the Treatment of Fabry Nephropathy gan Sandro Feriozzi, Joan Torrás, Markus Cybulla, Kathy Nicholls, Gere Sunder‐Plassmann, Michael L. West

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis

    HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis gan Christian Oesterreicher, Johann Hammer, Uwe Koch, Franz Pfeffel, Gere Sunder‐Plassmann, Dagmar Petermann, Christian Müller

    Cyhoeddwyd 1995
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey

    Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey gan Aleš Linhart, Christoph Kampmann, José Luis Zamorano, Gere Sunder‐Plassmann, Michael Beck, Atul Mehta, Perry Elliott

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey

    Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey gan Atul Mehta, Joe T.R. Clarke, Roberto Giugliani, Perry Elliott, Aleš Linhart, Michael Beck, Gere Sunder‐Plassmann

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients

    Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients gan Manuela Födinger, Christine Mannhalter, Gabriele Wölfl, Ingrid Pabinger, Eva Cignacco, Rainer Schmid, W.H. Hörl, Gere Sunder‐Plassmann

    Cyhoeddwyd 1997
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Impact of Measures to Enhance the Value of Observational Surveys in Rare Diseases: The Fabry Outcome Survey (FOS)

    Impact of Measures to Enhance the Value of Observational Surveys in Rare Diseases: The Fabry Outcome Survey (FOS) gan Joe T.R. Clarke, Roberto Giugliani, Gere Sunder‐Plassmann, Perry Elliott, Guillem Pintos‐Morell, Elizabeth Hernberg‐Ståhl, Maria Malmenäs, Michael Beck

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Single-Dose Pharmacokinetics of Meropenem during Continuous Venovenous Hemofiltration

    Single-Dose Pharmacokinetics of Meropenem during Continuous Venovenous Hemofiltration gan Florian Thalhammer, Peter Schenk, Heinz Burgmann, Ibrahim El Menyawi, Ursula Hollenstein, Alexander R. Rosenkranz, Gere Sunder‐Plassmann, Stefan Breyer, Klaus Ratheiser

    Cyhoeddwyd 1998
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Magnetic resonance imaging T1- and T2-mapping to assess renal structure and function: a systematic review and statement paper

    Magnetic resonance imaging T1- and T2-mapping to assess renal structure and function: a systematic review and statement paper gan Marcos Wolf, A de Boer, Kanishka Sharma, Peter Boor, Tim Leiner, Gere Sunder‐Plassmann, Ewald Moser, Anna Caroli, Neil P. Jerome

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters

    Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters gan Wolfgang Winnicki, Harald Herkner, Matthias Lorenz, Ammon Handisurya, Željko Kikić, Bernhard Bielesz, Benjamin Schairer, Thomas Reiter, Farsad Eskandary, Gere Sunder‐Plassmann, Guerkan Sengoelge

    Cyhoeddwyd 2017
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Employment Status and Associations with Workability, Quality of Life and Mental Health after Kidney Transplantation in Austria

    Employment Status and Associations with Workability, Quality of Life and Mental Health after Kidney Transplantation in Austria gan Galateja Jordakieva, Igor Grabovac, M. Steiner, Wolfgang Winnicki, Sabine Zitta, Siniša Štefanac, Moritz Brooks, Gere Sunder‐Plassmann, Alexander R. Rosenkranz, Jasminka Godnić‐Cvar

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

    Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey gan Atul Mehta, Renato Pietro Ricci, Urs Widmer, F. Dehout, A. García de Lorenzo, C. Kampmann, Aleš Linhart, Gere Sunder‐Plassmann, Markus Ries, Michael Beck

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome

    Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome gan Martina Gaggl, Christof Aigner, Dorottya Csuka, Ágnes Szilágyi, Zoltán Prohászka, Renate Kain, Natalja Haninger, Maarten Knechtelsdorfer, Raute Sunder‐Plaßmann, Gere Sunder‐Plassmann, Alice Schmidt

    Cyhoeddwyd 2017
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Efficacy and safety of pegcetacoplan in kidney transplant recipients with recurrent C3G or primary IC-MPGN

    Efficacy and safety of pegcetacoplan in kidney transplant recipients with recurrent C3G or primary IC-MPGN gan Andrew S. Bomback, Erica Daina, Giuseppe Remuzzi, John Kanellis, David Kavanagh, Matthew C. Pickering, Gere Sunder‐Plassmann, Patrick D. Walker, Zhongshen Wang, Zurish Ahmad, Fádi Fakhouri

    Cyhoeddwyd 2024
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: